Literature DB >> 24851211

Response: clinical marker of platelet hyperreactivity in diabetes mellitus (diabetes metab j 2013;37:423-8).

Jin Hwa Kim1, Hak Yeon Bae1, Sang Yong Kim1.   

Abstract

Entities:  

Year:  2014        PMID: 24851211      PMCID: PMC4021304          DOI: 10.4093/dmj.2014.38.2.160

Source DB:  PubMed          Journal:  Diabetes Metab J        ISSN: 2233-6079            Impact factor:   5.376


× No keyword cloud information.
We truly appreciate the interest and comments regarding our article, "Clinical marker of platelet hyperreactivity in diabetes mellitus," which was published in Diabetes & Metabolism Journal [1]. Our responses to the comments by Drs. Cengiz Beyan and Esin Beyan's are as follows: We suggested that mean platelet volume (MPV), which is used to measure platelet size, is a potential marker of platelet hyperreactivity in diabetes. Although some uncertainty remain, previous studies have also shown that MPV is a potential predictive marker of platelet hyperreactivity in diabetes [2,3,4,5]. Furthermore, Shah et al. [6] reported a significant correlation between MPV and the degree of glycemic control only in diabetic patients. They suggested that the positive relationship between an increased glucose level and increased MPV is a unique phenomenon of diabetes. Recent data from our group supports this possibility. We found a contrasting relationship between MPV and fasting plasma glucose in the presence and absence of diabetes in a general Korean population [7]. Nevertheless, we think that further large prospective studies should be conducted to confirm the clinical utility of this marker and to clarify the association between MPV and platelet hyperreactivity in diabetes. We agree with you about the correct measurement of MPV. There is a need for careful measurements and interpretation. However, current various methods that are used to measure platelet function are mostly complex and are not easily applicable in real clinical practice. On the other hand, although there are controversies about the most exact methodology for measuring MPV, it is easily accessible in the inpatient and outpatient settings at a relatively low cost. For this reason we believe that bolstering the strengths to make up for the weaknesses may provide an alternative route for better diagnosis, but further studies are still required. Thank you for your interest in this article and for your thoughtful comments.
  7 in total

1.  The relationship of platelet count, mean platelet volume with metabolic syndrome according to the criteria of the American Association of Clinical Endocrinologists: a focus on gender differences.

Authors:  Byoung-Jin Park; Jae-Yong Shim; Hye-Ree Lee; Dong-Hyuk Jung; Jung-Hyun Lee; Yong-Jae Lee
Journal:  Platelets       Date:  2011-07-07       Impact factor: 3.862

2.  Coronary heart disease is associated with mean platelet volume in type 2 diabetic patients.

Authors:  Yusuf Tavil; Nihat Sen; Hüseyin Yazici; Murat Turfan; Fatma Hizal; Atiye Cengel; Adnan Abaci
Journal:  Platelets       Date:  2010       Impact factor: 3.862

3.  The relationship between mean platelet volume with microalbuminuria and glycemic control in patients with type II diabetes mellitus.

Authors:  Mustafa Ünübol; Medıha Ayhan; Engın Güney
Journal:  Platelets       Date:  2011-11-29       Impact factor: 3.862

Review 4.  Mean platelet volume: a link between thrombosis and inflammation?

Authors:  Armen Yuri Gasparyan; Lilit Ayvazyan; Dimitri P Mikhailidis; George D Kitas
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

5.  The relationship between mean platelet volume and fasting plasma glucose differs with glucose tolerance status in a Korean general population: gender differences.

Authors:  Jin Hwa Kim; Seung Bum Kang; Ji In Kang; Jin Woo Kim; Sang Yong Kim; Hak Yeon Bae
Journal:  Platelets       Date:  2012-08-23       Impact factor: 3.862

6.  The relationship between diabetes, metabolic syndrome, and platelet activity as measured by mean platelet volume: the National Health And Nutrition Examination Survey, 1999-2004.

Authors:  Binita Shah; Daohang Sha; Dawei Xie; Emile R Mohler; Jeffrey S Berger
Journal:  Diabetes Care       Date:  2012-03-12       Impact factor: 19.112

7.  Clinical marker of platelet hyperreactivity in diabetes mellitus.

Authors:  Jin Hwa Kim; Hak Yeon Bae; Sang Yong Kim
Journal:  Diabetes Metab J       Date:  2013-12       Impact factor: 5.376

  7 in total
  4 in total

1.  Association of hematological indicies with diabetes, impaired glucose regulation and microvascular complications of diabetes.

Authors:  Levent Demirtas; Husnu Degirmenci; Emin Murat Akbas; Adalet Ozcicek; Aysu Timuroglu; Ali Gurel; Fatih Ozcicek
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  Prevalence and risk factors of diabetic retinopathy in patients with type 2 diabetes in Shanghai.

Authors:  Pei Zhang; Wen-Wen Xue; Xiao-Bo Huang; Yi Xu; Li-Na Lu; Kai-Rong Zheng; Hai-Dong Zou
Journal:  Int J Ophthalmol       Date:  2021-07-18       Impact factor: 1.779

Review 3.  The relationship between mean platelet volume and diabetic retinopathy: a systematic review and meta-analysis.

Authors:  ShuaiFei Ji; Jie Zhang; XiuDe Fan; XiQiang Wang; XiaoNa Ning; BaBo Zhang; Heng Shi; Hong Yan
Journal:  Diabetol Metab Syndr       Date:  2019-03-12       Impact factor: 3.320

4.  Effects of statin therapy on mean platelet volume in patients with risk of cardiovascular diseases: a systematic review and meta-analysis.

Authors:  Shuaifei Ji; Babo Zhang; Xianda Wang; Heng Shi; Lixin Yu; Xiaocheng Wang
Journal:  Biosci Rep       Date:  2019-07-25       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.